Showing results (1661-1670 of 2,265) with videos related to

Sort By:
Pageof 227
Blood|April 15, 1997
Expression of the RET receptor tyrosine kinase and GDNFR-alpha in normal and leukemic human hematopoietic cells and stromal cells of the bone marrow microenvironmentV Gattei, A Celetti, A Cerrato, et al.
Endocrinology|July 19, 2001
Evidence of an orexigenic role for cocaine- and amphetamine-regulated transcript after administration into discrete hypothalamic nucleiC R Abbott, M Rossi, A M Wren, et al.
Transplantation Proceedings|August 19, 2007
Modifications of intracranial pressure after molecular adsorbent recirculating system treatment in patients with acute liver failure: case reportsF Pugliese, F Ruberto, S M Perrella, et al.
Mutation Research|November 19, 2011
Genotoxicity of inhaled nanosized TiO(2) in miceHanna K Lindberg, Ghita C-M Falck, Julia Catalán, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 8, 2020
Incompletely excised lentigo maligna melanoma is associated with unpredictable residual disease: clinical features and the emerging role of reflectance confocal microscopyC Navarrete-Dechent, S Aleissa, M Cordova, et al.
Molecular Syndromology|April 10, 2014
Identification of Nine New RAI1-Truncating Mutations in Smith-Magenis Syndrome Patients without 17p11.2 DeletionsC Dubourg, F Bonnet-Brilhault, A Toutain, et al.
Journal of Neurosurgical Sciences|March 18, 2022
Successful staged separation of total angular craniopagusCarlo E Marras, Andrea Carai, Alessandro DE Benedictis, et al.
Structural Dynamics (Melville, N.Y.)|August 3, 2019
Exploring the multiparameter nature of EUV-visible wave mixing at the FERMI FELL Foglia, F Capotondi, H Höppner, et al.
The Journal of Experimental Medicine|June 15, 2016
G9a regulates group 2 innate lymphoid cell development by repressing the group 3 innate lymphoid cell programFrann Antignano, Mitchell Braam, Michael R Hughes, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 20, 2019
Outpatient dermatology consultations for oncology patients with acute dermatologic adverse events impact anticancer therapy interruption: a retrospective studyD M Barrios, G S Phillips, A Freites-Martinez, et al.
Pageof 227